Latest News about Rare
Recent news which mentions Rare
Ultragenyx's Multiple Commercial Assets And Candidates Impress Analyst; Sees Solid Upside
January 15, 2025
From Benzinga
From Benzinga
Evaluating Ultragenyx Pharmaceutical: Insights From 7 Financial Analysts
November 06, 2024
Tickers
RARE
From Benzinga
A Look Ahead: Ultragenyx Pharmaceutical's Earnings Forecast
November 04, 2024
Tickers
RARE
From Benzinga
Decoding 10 Analyst Evaluations For Ultragenyx Pharmaceutical
October 21, 2024
Tickers
RARE
From Benzinga
Breaking Down Ultragenyx Pharmaceutical: 10 Analysts Share Their Views
September 20, 2024
Tickers
RARE
From Benzinga
Novartis And Viatris Sued Over Unlawful Use Of HeLa Cells Used For Cancer Treatment Drugs
August 06, 2024
From Benzinga
3 Genomics Stocks That May Transform Personalized Medicine
August 06, 2024
From InvestorPlace
Ionis' Rare Development Disorder Drug Candidate 'Could Be Differentiated' From Peer Ultragenyx: Analyst
July 22, 2024
From Benzinga
From InvestorPlace
Why AMMO Shares Are Trading Lower By Over 19%? Here Are Other Stocks Moving In Friday's Mid-Day Session
June 14, 2024
From Benzinga
Dave & Buster's Posts Downbeat Results, Joins J.Jill And Other Big Stocks Moving Lower In Thursday's Pre-Market Session
June 13, 2024
From Benzinga
From Benzinga
From Benzinga
Tickers
RARE
From InvestorPlace
S&P 500 Down Over 1%; US Retail Sales Increase 0.7% In March
April 15, 2024
From Benzinga
Why Ultragenyx Pharmaceutical Shares Are Trading Lower By Around 9%? Here Are Other Stocks Moving In Monday's Mid-Day Session
April 15, 2024
From Benzinga
Crude Oil Down 1%; Charles Schwab Sales Top Estimates
April 15, 2024
From Benzinga
Rare Disease-Focused-Ultragenyx Pharmaceutical Stock Falls On Serious Adverse Events In Eaarly Genetic Disorder Study
April 15, 2024
From Benzinga
Marinus Pharmaceuticals, Neumora Therapeutics And Other Big Stocks Moving Lower In Monday's Pre-Market Session
April 15, 2024
From Benzinga
Analyst Scoreboard: 8 Ratings For Ultragenyx Pharmaceutical
March 18, 2024
Tickers
RARE
From Benzinga
The Latest Analyst Ratings For Ultragenyx Pharmaceutical
February 15, 2024
Tickers
RARE
From Benzinga
Earnings Scheduled For February 15, 2024
February 15, 2024
From Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.